AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Bill Tracker · Massachusetts

S1400

Authorizing a pilot for the use of psychedelics in licensed treatment facilities

Status

Pending

2025 Session

IntroducedFeb 27, 2025 (done)
PassedNext step (current)
Signed— (upcoming)
Law in effect— (upcoming)

Sponsor: Cindy Friedman (Democrat)
Type: Therapeutic Access
Substances: Psilocybin

Official text

Summary (from PoliPsy)

For legislation to authorize a pilot for the use of psychedelics in licensed treatment facilities. Mental Health, Substance Use and Recovery.

The full bill text and every version are kept by the legislature. We link to it rather than copy it so readers always see the current version.

Read the full bill text

Source: malegislature.gov

Legislative history

October 2, 2025
Referred
October 2, 2025
Referred
September 11, 2025
Referred
February 27, 2025
Referred
February 27, 2025
Introduced

Loading bill…